It will be tight between money running out and getting statistically significant results. Clinical Trial I'm reading this as they will have 77 results when these 58 active are finished. If they recruit at the same rate, they might hit 130-140 by the end of quarter one, Will they have the money to get to then? They say they have 2 quarters left but they will need to raise before that runs out. There will be about $580 000 Ashland. Maybe another $ 250,000 in January. They probably have another $ 400,000 from the RD loan. That might get them to April. However, there are positives. They can do an interim statistical analysis earlier. It increases the risk, but only if the results look promising. The extra sites might increase recruitment. A license agreement could be reached if they can present some statistically significant results, which would fund the rest of the trial. It is 60/40 chance at the moment of getting to the data they need. And then it is a 50/50 chance of positive results. I'm bullish. The recent buying activity suggests someone is in the know. I'd expect some additional announcements soon.
AVE Price at posting:
0.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)